RxPG News Feed for RxPG News

Medical Research Health Special Topics World
  Home
 
   Health
 Aging
 Asian Health
 Events
 Fitness
 Food & Nutrition
 Happiness
 Men's Health
 Mental Health
 Occupational Health
 Parenting
 Public Health
 Sleep Hygiene
 Women's Health
 
   Healthcare
 Africa
 Australia
 Canada Healthcare
 China Healthcare
 India Healthcare
 New Zealand
 South Africa
 UK
 USA
 World Healthcare
 
   Latest Research
 Aging
 Alternative Medicine
 Anaethesia
 Biochemistry
 Biotechnology
 Cancer
 Cardiology
 Clinical Trials
 Cytology
 Dental
 Dermatology
 Embryology
 Endocrinology
 ENT
 Environment
 Epidemiology
 Gastroenterology
 Genetics
 Gynaecology
 Haematology
 Immunology
 Infectious Diseases
 Medicine
 Metabolism
 Microbiology
 Musculoskeletal
 Nephrology
 Neurosciences
 Obstetrics
 Ophthalmology
 Orthopedics
 Paediatrics
 Pathology
 Pharmacology
 Physiology
 Physiotherapy
 Psychiatry
  Anorexia Nervosa
  Anxiety
  Bulimia
  CFS
  Child Psychiatry
  Depression
  Forensic Psychiatry
  Learning-Disabilities
  Mood Disorders
  Neuropsychiatry
  Peri-Natal Psychiatry
  Personality Disorders
  Psychology
  Psychoses
  Psychotherapy
  Sleep Disorders
  Substance Abuse
   Alcohol
   Amphetamine
   Cannabis
   Cocaine
   Opiates
   Smoking
  Suicide
 Radiology
 Rheumatology
 Sports Medicine
 Surgery
 Toxicology
 Urology
 
   Medical News
 Awards & Prizes
 Epidemics
 Launch
 Opinion
 Professionals
 
   Special Topics
 Ethics
 Euthanasia
 Evolution
 Feature
 Odd Medical News
 Climate

Last Updated: Oct 11, 2012 - 10:22:56 PM
Smoking Channel

subscribe to Smoking newsletter
Latest Research : Psychiatry : Substance Abuse : Smoking

   EMAIL   |   PRINT
Smokers assume false sense of safety from ads for low nicotine cigarettes

Mar 27, 2006 - 4:12:00 AM , Reviewed by: Priya Saxena
"This study is the first to evaluate how regular smokers responded to a print ad for Quest cigarettes, a newly developed cigarette marketed as a way to gradually reduce nicotine exposure via smoking cigarettes that are lower in nicotine,"

 
[RxPG] A study by researchers at the Transdisciplinary Tobacco Use Research Center of the University of Pennsylvania School of Medicine found that many smokers make false inferences about the safety of new low nicotine cigarettes.

"This study is the first to evaluate how regular smokers responded to a print ad for Quest cigarettes, a newly developed cigarette marketed as a way to gradually reduce nicotine exposure via smoking cigarettes that are lower in nicotine," said author Caryn Lerman, PhD, Associate Director for Cancer Control and Population Science at the Abramson Cancer Center of the University of Pennsylvania, and Professor in Penn's School of Medicine and the Annenberg Public Policy Center.

Quest® cigarettes are a brand of low-nicotine cigarettes manufactured by Vector Tobacco, Inc., and currently marketed in eight US states. Quest® cigarettes, both regular and menthol, are manufactured with three progressively lower nicotine levels and marketed as allowing smokers to "step-down" nicotine levels to enjoy "nicotine-free smoking." Anti-smoking advocates highlight the long-term health effects – like cancer and emphysema – that result from a lifetime of smoking or chewing tobacco. These maladies, however, are the result of chemicals in cigarettes other than nicotine. While Quest® cigarettes do offer reduced nicotine levels, they do not have progressively less tar and thus, still pose significant health risks. Given evidence that many smokers misinterpret the information contained in marketing campaigns for such "light" cigarettes it is important to understand how smokers perceive this newly marketed low nicotine cigarette.

Lerman led a research team that examined the response of 200 regular smokers to a Quest ® cigarette print advertisement using a mall intercept survey approach. Participants viewed a single Quest® cigarette print advertisement and then were asked to answer a series of questions about their smoking and quitting history, beliefs about Quest® cigarettes, perceived vulnerability to the health effects of smoking, and the "need for cognition" – or how much people like to think critically about information. Researchers found that as many as 45% of smokers made false inferences about the tar content of Quest® cigarettes. Also, smokers who felt less vulnerable to the health effects of smoking and who do not enjoy thinking critically about issues made more false inferences about the potential harms of Quest® cigarettes.

"These results reinforce the need for public health awareness campaigns to relay the message that smoking any cigarettes – regardless of nicotine content – can have deleterious health effects," said co-author Andrew Strasser, PhD. This research was funded by the



Publication: This research appears in the March issue of Psychology of Addictive Behaviors.
On the web: www.pennhealth.com/cancer 

Advertise in this space for $10 per month. Contact us today.


Related Smoking News
Exposure to smoking-cessation product ads helps smokers quit
Want to quit smoking? Therapy and willpower can help
Smokers lose more muscle in old age: study
Children of smokers have more than 5 times higher levels of a nicotine toxin
Nicotine addiction depends on a healthy insula
Knee osteoarthritis more painful for smokers: study
Cutting down cigarettes does not reduce health risk
C. elegans provides model for the genetics of nicotine dependence
Smoking Ban Associated With Rapid Improvement In Health Of Bar Workers in Scotland
Smoking media literacy (SML) is a valuable tool in efforts to discourage teens from smoking

Subscribe to Smoking Newsletter

Enter your email address:


 Additional information about the news article
National Cancer Institute and was conducted by the University of Pennsylvania Transdisciplinary Tobacco Use Research Center and the Center of Excellence in Cancer Communication Research.

About the Abramson Cancer Center:
The Abramson Cancer Center of the University of Pennsylvania was established in 1973 as a center of excellence in cancer research, patient care, education and outreach. Today, the Abramson Cancer Center ranks as one of the nation's best in cancer care, according to US News and World Report, and is one of the top five in National Cancer Institute (NCI) funding. It is one of only 39 NCI-designated comprehensive cancer centers in the United States. Home to one of the largest clinical and research programs in the world, the Abramson Cancer Center of the University of Pennsylvania has 275 active cancer researchers and 250 Penn physicians involved in cancer prevention, diagnosis and treatment. More information about the Abramson Cancer Center is available at: www.pennhealth.com/cancer
 Feedback
For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 
Contact us

RxPG Online

Nerve

 

    Full Text RSS

© All rights reserved by RxPG Medical Solutions Private Limited (India)